GlaxoSmithKline

Prosecutors in China Charge Investigators Linked to GSK for Illegally Obtaining Data

Prosecutors in China Charge Investigators Linked to GSK for Illegally Obtaining DataIn the recent years China has made arrangements to make its privacy laws stricter. The country amended its criminal policy to forbid the transfer, sale or gathering of information of any Chinese citizens by the government firms and companies who are involved in telecom business, education transportation and medical treatment, in 2009.

Injectable Asthma Drugs to Replace Traditional Inhalers

asthmaAsthma inhalers are bidding bye as injectable biotech asthma drugs have emerged as a much better treatment, especially for patients with severe asthma. They are effective in patients not benefitted by traditional inhalers. The injectable treatment for asthma has unleashed a race among rival pharmaceutical firms to establish a strong foothold in a new market worth a more than $7.5 billion.

GSK Terminates its collaboration with Prosensa

GlaxoSmithKlineGlaxoSmithKline (GSK) has finished its partnership with Dutch biopharma company, Prosensa. The partnership was regarding the development of a treatment for Duchenne muscular dystrophy (DMD).

Doctors will get no payments from GlaxoSmithKline for drug promotion

Doctors will get no payments from GlaxoSmithKline for drug promotionBritish drug organization GlaxoSmithKline says it will quit offering fiscal backing to specialists and other human services experts to advertise its items.

GSK says it will no more pay human services experts to talk for its sake to crowds that can recommend prescriptions and will quit giving money related backing to experts to go to medicinal gatherings.

GlaxoSmithKline to increase stake in Indian subsidiary by Rs 6.38K crore

GlaxoSmithKline to increase stake in Indian subsidiary by Rs 6.38K croreGlaxoSmithKline Pharmaceutical's shares touched a 52-week high of Rs2,952 apiece on the NSE after its UK parent GlaxoSmithKline (GSK)  said it will spend Rs6,389 crore (£629 million) to raise stake in its Indian unit, GlaxoSmithKline Pharmaceuticals, through a voluntary open offer.

Parents told Not to give Panadol to their Children

PanadolAn urgent safety warning has been issued by GlaxoSmithKline to drop the use of Panadol for small babies. Parents have been advised to immediately take their children to hospitals, who had given their children this drug.

Relvar Ellipta Gets EU’s Green Signal for Asthma Treatment

GlaxoSmithKlineAccording to a latest report, GlaxoSmithKline PLC (GSK. LN) and US drug developer Theravance Inc. (THRX) have received green signal from the European Commission. These pharmaceutical giants have recently received the marketing approval of the EU for their joint venture.

According to sources, theses companies will now be able to market their jointly-developed asthma treatment named as Relvar Ellipta.

Syndicate content